GO:0032184 SUMO polymer binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032184 SUMO polymer binding is a molecular function defined as binding to a polymer of the small ubiquitin-like protein SUMO.
• SUMO polymers (polySUMO chains) act as polymeric signals that are recognized by dedicated reader proteins and enzymes.
• Noncovalent SUMO polymer binding is essential for the activity of SUMO proteases and for cell growth.
• SUMO polymer binding is mechanistically distinct from ubiquitin chain recognition, although both use similar structural folds.
• Dysregulated SUMO polymer binding contributes to cancer progression, including lung adenocarcinoma and prostate cancer.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of SUMO polymer binding proteins.
Description
SUMO polymer binding (GO:0032184) is a molecular function that enables a protein to selectively recognize and bind to polymeric chains of small ubiquitin-like modifier (SUMO) proteins. SUMOylation is a post-translational modification in which SUMO moieties are covalently attached to lysine residues of target proteins, and the resulting polySUMO chains serve as polymeric signals that recruit effector proteins. The ability to bind SUMO polymers is therefore a critical node in SUMO-dependent signaling, linking the modification to downstream cellular responses. Researchers study this function to understand how cells decode SUMO chain topology and how defects in this recognition contribute to disease. The QuickGO definition of GO:0032184 is binding to a polymer of the small ubiquitin-like protein SUMO, with the synonym Smt3 polymer binding. This function is distinct from binding to monomeric SUMO or to ubiquitin polymers, although structural and mechanistic parallels exist between these recognition systems. Noncovalent SUMO polymer binding is required for the enzymatic activity of SUMO proteases and for normal cell growth, highlighting its physiological importance. In cancer, SUMO polymer binding proteins such as CORO1C are implicated in cytoskeletal remodeling and tumor progression. In apoptosis, N-terminal alpha-amino SUMOylation of cofilin-1 promotes its translocation to the mitochondrial matrix, a process that may involve SUMO polymer recognition. Viral proteins can also manipulate SUMO modifications, as shown for adenovirus E4-ORF3, further underscoring the broad relevance of SUMO polymer binding.
SUMO polymer binding At A Glance
| GO ID | GO:0032184 |
|---|---|
| GO term | SUMO polymer binding |
| Ontology | molecular_function |
| Synonym | Smt3 polymer binding |
| Definition | Binding to a polymer of the small ubiquitin-like protein SUMO. |
| Major function | Recognition of polySUMO chains as polymeric signals for downstream cellular processes. |
| Related modification | SUMOylation (covalent attachment of SUMO to target lysines). |
| Example reader proteins | SUMO proteases, SIM-containing proteins, and viral effectors. |
| Disease relevance | Cancer, apoptosis, and viral pathogenesis. |
What Is GO:0032184?
GO:0032184 SUMO polymer binding describes the molecular function of selectively binding to a polymer (chain) of SUMO proteins. It is a molecular_function term in the Gene Ontology, with the synonym Smt3 polymer binding. This function is mediated by SUMO-interacting motifs (SIMs) or related domains that recognize the polymeric arrangement of SUMO moieties, enabling downstream signaling, enzymatic regulation, or substrate targeting.
Why Is SUMO polymer binding Important in Cell Biology?
SUMO polymer binding is important because polySUMO chains function as polymeric signals that regulate diverse cellular processes, including transcription, DNA repair, cell cycle progression, and apoptosis. Proteins that bind SUMO polymers can act as readers that translate the SUMO code into specific outcomes, and their dysfunction is linked to cancer and other diseases. Understanding this function is therefore essential for decoding SUMO biology and for developing therapeutic strategies that target SUMO-dependent pathways.
• SUMO polymers serve as polymeric signals that are decoded by SUMO polymer binding proteins.
• Noncovalent SUMO polymer binding is necessary for SUMO protease activity and cell growth.
• SUMO polymer binding is mechanistically related to ubiquitin chain recognition, informing broader signaling principles.
• Dysregulation of SUMO polymer binding contributes to lung adenocarcinoma progression.
• SUMO polymer binding is implicated in apoptosis via cofilin-1 SUMOylation.
• Viral proteins such as adenovirus E4-ORF3 manipulate SUMO modifications, highlighting host-pathogen interactions.
• SUMO polymer binding is relevant to prostate cancer cell survival and PANoptosis.
• Targeting SUMO polymer binding proteins may offer new therapeutic opportunities in oncology.
• SUMO chain topology influences the specificity of reader proteins, making it a key research area.
• CRISPR-based models enable functional dissection of SUMO polymer binding in disease contexts.
Molecular Mechanism of SUMO polymer binding
Recognition of PolySUMO Chains by SIMs
In simple terms: Proteins use small pockets called SIMs to grab onto SUMO chains.
SUMO polymer binding is primarily mediated by SUMO-interacting motifs (SIMs), short hydrophobic stretches that bind to the SUMO surface. PolySUMO chains present multiple SUMO moieties, allowing multivalent interactions that increase affinity and specificity. This recognition is distinct from ubiquitin chain binding, although both use similar structural principles.
Noncovalent Binding by SUMO Proteases
In simple terms: SUMO proteases need to hold onto SUMO chains to cut them properly.
SUMO proteases (e.g., SENP1, SENP2) contain noncovalent SUMO-binding sites that are required for their enzymatic activities and for cell growth. Mutations that abolish noncovalent SUMO polymer binding impair protease function, demonstrating that binding is not merely regulatory but essential.
PolySUMO Chains as Signaling Platforms
In simple terms: SUMO chains act like molecular flags that recruit specific proteins.
PolySUMO chains serve as polymeric signals that recruit effector proteins to specific cellular locations or substrates. This recruitment can alter protein-protein interactions, enzymatic activities, or subcellular localization, thereby propagating SUMO-dependent signaling.
Viral Manipulation of SUMO Polymer Binding
In simple terms: Some viruses hijack SUMO chain recognition to control host cells.
Adenovirus E4-ORF3 promotes SUMO modifications and can reorganize SUMO-dependent pathways, illustrating how viral proteins exploit SUMO polymer binding for pathogenesis.
SUMO Polymer Binding in Apoptosis and Cytoskeletal Remodeling
In simple terms: SUMO chain recognition can trigger cell death or shape cell movement.
N-terminal alpha-amino SUMOylation of cofilin-1 promotes its translocation to the mitochondrial matrix and induces apoptosis, a process that may involve SUMO polymer binding. In lung adenocarcinoma, UBC9-mediated SUMOylation of CORO1C drives progression via Arp2/3-dependent cytoskeletal remodeling, highlighting the role of SUMO polymer binding in cancer cell motility.
Key Genes Involved in GO:0032184 SUMO polymer binding
The following genes and proteins are experimentally linked to SUMO polymer binding or its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SUMO1 | Small ubiquitin-like modifier; forms polymers | Core component of SUMO chains |
| SUMO2 | Small ubiquitin-like modifier; forms polymers | PolySUMO chain formation |
| SUMO3 | Small ubiquitin-like modifier; forms polymers | PolySUMO chain formation |
| UBC9 | SUMO-conjugating enzyme | SUMOylation of substrates like CORO1C |
| SENP1 | SUMO protease | Noncovalent SUMO binding required for activity |
| SENP2 | SUMO protease | Noncovalent SUMO binding required for activity |
| CORO1C | Actin-binding protein | SUMOylation drives lung adenocarcinoma progression |
| CFL1 | Cofilin-1, actin depolymerizing factor | N-terminal SUMOylation promotes apoptosis |
| E4-ORF3 | Adenovirus protein | Manipulates SUMO modifications |
| RANBP2 | SUMO E3 ligase | SUMO chain formation and binding |
| PIAS1 | SUMO E3 ligase | SUMOylation and chain recognition |
| SIM-containing proteins | SUMO-interacting motif readers | Bind polySUMO chains |
| UBE2I | SUMO-conjugating enzyme (UBC9) | SUMOylation and polymer binding |
| TNF-alpha | Cytokine | Induces PANoptosis in prostate cancer |
| Arp2/3 complex | Actin nucleation | Cytoskeletal remodeling downstream of SUMO |
| Cofilin-1 | Actin dynamics | Mitochondrial translocation via SUMOylation |
| SUMO proteases | DeSUMOylation | Noncovalent SUMO binding for activity |
How Is SUMO polymer binding Regulated?
SUMO polymer binding is regulated by the availability of polySUMO chains, which depends on the balance between SUMO conjugation (E1, E2, E3 enzymes) and deSUMOylation by SUMO proteases. Noncovalent SUMO binding by proteases is required for their catalytic activity, creating a feedback loop that controls chain dynamics. Viral proteins such as E4-ORF3 can alter SUMO modification patterns, thereby indirectly regulating SUMO polymer binding. Additionally, phosphorylation and other post-translational modifications of SIM-containing proteins may modulate their affinity for SUMO polymers.
SUMO polymer binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CORO1C | Lung adenocarcinoma progression | KO and overexpression in A549 cells |
| CFL1 | Apoptosis, mitochondrial translocation | Point mutation of SUMOylation site |
| E4-ORF3 | Viral pathogenesis | Knock-in of viral gene in human cells |
| SENP1 | Cell growth and protease activity | KO and point mutation |
| TNF-alpha | Prostate cancer PANoptosis | Overexpression and KO in PC-3 cells |
SUMO Polymer Binding in Cancer
Dysregulated SUMO polymer binding contributes to cancer progression. In lung adenocarcinoma, UBC9-mediated SUMOylation of CORO1C drives tumor progression via Arp2/3-dependent cytoskeletal remodeling, suggesting that SUMO polymer recognition is important for cancer cell motility and invasion. In prostate cancer, PLA inhibits TNF-alpha-induced PANoptosis through metabolic reprogramming, a process that may intersect with SUMO-dependent pathways.
SUMO Polymer Binding in Apoptosis
N-terminal alpha-amino SUMOylation of cofilin-1 promotes its translocation to the mitochondrial matrix and induces apoptosis, linking SUMO polymer binding to cell death regulation. This mechanism may be relevant to neurodegenerative diseases and cancer therapy.
Viral Pathogenesis and SUMO Polymer Binding
Adenovirus E4-ORF3 mediates SUMO modifications, including polymer formation, to manipulate host cell processes. This highlights how viruses exploit SUMO polymer binding for replication and immune evasion.
From SUMO polymer binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SUMO polymer binding affect cell growth? | CRISPR KO of SENP1/2 |
| Does a point mutation in a SIM abolish polySUMO binding? | Point mutation knock-in |
| Can SUMOylation site mutation prevent cofilin-1 apoptosis? | Point mutation knock-in of CFL1 |
| Does CORO1C SUMOylation drive lung cancer progression? | Knock-in of SUMOylated CORO1C |
| Can overexpression of E4-ORF3 alter SUMO polymers? | Overexpression in human cells |
| Does SUMO polymer binding regulate PANoptosis? | KO of SUMO pathway genes in prostate cancer cells |
How to Study the SUMO polymer binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pull-down with polySUMO | Binding affinity | Identify SUMO polymer binding proteins |
| Mass spectrometry | Protein interactions | Proteomic discovery of SIM proteins |
| NMR spectroscopy | Structural interactions | Map SIM-SUMO interfaces |
| FRET/BRET | Binding in live cells | Measure SUMO polymer binding dynamics |
| CRISPR KO screen | Gene essentiality | Find regulators of SUMO polymer binding |
| Western blot | SUMOylation levels | Assess polySUMO chain formation |
| Immunofluorescence | Subcellular localization | Track SUMO polymer binding proteins |
| RNA-seq | Transcriptional changes | Downstream effects of SUMO polymer binding |
Proteomic Identification of SUMO Polymer Binding Proteins
Affinity purification using polySUMO chains followed by mass spectrometry can identify novel SUMO polymer binding proteins. This approach has been used to characterize SIM-containing proteins and SUMO proteases.
Structural Biology of SUMO Polymer Recognition
NMR and crystallography can reveal how SIMs engage polySUMO chains. Structural studies of SUMO proteases have shown the importance of noncovalent SUMO binding for catalysis.
Functional Assays for SUMO Polymer Binding
In vitro binding assays (e.g., pull-downs, SPR) and cell-based assays (e.g., FRET) can measure SUMO polymer binding affinity and specificity. Mutational analysis of SIMs is commonly used.
CRISPR Screens for SUMO Pathway Components
Genome-wide CRISPR knockout screens can identify genes required for SUMO polymer binding-dependent phenotypes, such as cell growth or drug resistance.
How CRISPR Can Be Used to Study GO:0032184 SUMO polymer binding
Knockout
CRISPR knockout of SUMO proteases (SENP1, SENP2) or SUMO ligases (UBC9) can abolish SUMO polymer binding and reveal its role in cell growth and stress responses.
Point Mutation
Point mutations in SIMs or catalytic cysteines can specifically disrupt SUMO polymer binding without affecting protein stability, allowing precise functional dissection.
Knock-in
Knock-in of tagged SUMO or SUMO-binding domains enables visualization and affinity purification of SUMO polymers in native contexts.
Overexpression
Overexpression of SUMO polymers or SUMO-binding proteins can amplify SUMO-dependent signaling and model disease states such as cancer.
How EDITGENE Supports SUMO polymer binding Research
Researchers studying SUMO polymer binding-related genes often need to determine whether a candidate gene is causally involved in polySUMO recognition, downstream signaling, or disease progression. EDITGENE provides comprehensive CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for SUMO polymer binding research.
Frequently Asked Questions About SUMO polymer binding
What is SUMO polymer binding?
SUMO polymer binding (GO:0032184) is the molecular function of binding to a polymer of the small ubiquitin-like protein SUMO.
What genes are involved in SUMO polymer binding?
Key genes include SUMO1, SUMO2, SUMO3, UBC9, SENP1, SENP2, and SIM-containing proteins.
What is the GO ID for SUMO polymer binding?
The GO ID is GO:0032184.
What is the synonym for SUMO polymer binding?
The synonym is Smt3 polymer binding.
How is SUMO polymer binding studied?
It is studied using pull-down assays, mass spectrometry, structural biology, and CRISPR screens.
What diseases are linked to SUMO polymer binding?
Cancer, apoptosis, and viral pathogenesis are linked to SUMO polymer binding.
Is SUMO polymer binding the same as ubiquitin binding?
No, SUMO polymer binding is distinct, although both use similar structural folds.
What is the role of noncovalent SUMO binding in proteases?
Noncovalent SUMO binding is required for SUMO protease activity and cell growth.
Can CRISPR be used to study SUMO polymer binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used.
What is the definition of GO:0032184?
Binding to a polymer of the small ubiquitin-like protein SUMO.
Conclusion
SUMO polymer binding (GO:0032184) is a fundamental molecular function that decodes polySUMO chains into specific cellular outcomes. Its roles in cancer, apoptosis, and viral pathogenesis make it a compelling target for basic and translational research. CRISPR-based models and EDITGENE services provide powerful tools to dissect the mechanisms and disease relevance of SUMO polymer binding.
References
- 1. Mevissen TET et al.. 2017. Mechanisms of Deubiquitinase Specificity and Regulation.. Annu Rev Biochem 86:159-192 PMID: 28498721
- 2. Deng Q et al.. 2025. N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis.. Nat Commun 16(1):11687 PMID: 41309693
- 3. Sohn SY et al.. 2019. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.. mBio 10(1) PMID: 30808699
- 4. Vertegaal AC. 2010. SUMO chains: polymeric signals.. Biochem Soc Trans 38(Pt 1):46-9 PMID: 20074033
- 5. Ihara M et al.. 2007. Noncovalent binding of small ubiquitin-related modifier (SUMO) protease to SUMO is necessary for enzymatic activities and cell growth.. J Biol Chem 282(22):16465-75 PMID: 17428805
- 6. Zhang Z et al.. 2026. UBC9-mediated SUMOylation of CORO1C drives lung adenocarcinoma progression via Arp2/3-dependent cytoskeletal remodeling.. Cell Death Dis 17(1) PMID: 41912501
- 7. Vertegaal AC. 2007. Small ubiquitin-related modifiers in chains.. Biochem Soc Trans 35(Pt 6):1422-3 PMID: 18031236
- 8. Hao Y et al.. 2024. PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming.. Int J Biochem Cell Biol 169:106554 PMID: 38408537
